The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, San Diego.
The combo halts glioblastoma stem cells, markedly shrinks tumours and improves survival in mice, the study, published in the journal Science Translational Medicine, says.